enzyvant

1 stories · following the connections

Business

Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences

By Nasdaq OMXFeb 21, 2018, 1:05 PM UTC